- A foreign investor is reported to be behind the large turnover in shares of drugs producer Human on the Budapest Stock Exchange in the first week of June, according to MTI Econews. A total of 111,000 shares in Human changed hands during the week, with the firm's share price increasing from 1,550 forint ($10.17) per share to a 12-month high of 1,900 forint per share. The firm is known to have purchased 11,000 of its own shares, but commentators say that this would not explain the surge in the share price.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze